Enbridge (NYSE:ENB) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.54 by 24.07 percent. This is a 24.07 percent increase over earnings of $0.54 per share from the same period last year.
4DMT Presents Interim Data From 4D-310 INGLAXA Phase 1/2 Clinical Trials For Fabry Disease Cardiomyopathy At WORLDSymposium 2024
4D-310 demonstrated clinically meaningful cardiac endpoint improvements through 12-24 months in contractility (echocardiography), peak VO2 (cardiopulmonary exercise testing) and/or cardiac quality of life (KCCQ) in all